Dr Malcolm Haddrick
Malcolm is a Lead Scientist at MDC with 20+ years of experience in diverse Drug Discovery projects for efficacy and safety targets working at Pfizer and AstraZeneca. Malcolm has a PhD from the University of Leicester, followed by a postdoctoral position at the NIH in the USA studying HIV-1 pathogenesis. At MDC, his current role […]
John Vincent
John is a senior scientist with more than 25 years of experience in drug discovery roles, developing biochemical and cellular assays in a range of technologies and formats, utilising an array of laboratory equipment and automation. John has a degree from the University of Nottingham and previously worked for 23 years at AstraZeneca in roles […]
Dr Lorna Fitzpatrick
Lorna is a Lead scientist with over ten years’ of experience in molecular biology and genetic engineering in primary, stem and cancer cells. Lorna has a PhD from St. George’s University of London and carried out post-doctoral research at Manchester Metropolitan University before joining Medicines Discovery Catapult. In her current role, Lorna develops reporter models […]
Georgia Smith
For press and media enquiries, contact via: +44 7787 901331 Email: media@md.catapult.org.uk
Ailsa Gardner
For press and media enquiries, contact via: Phone: +447741 857132 Email: media@md.catapult.org.uk
Paul Beastall
Paul is the nominated Director for Innovate UK on the Board of Medicines Discovery Catapult and was appointed in 2022. He is an engineer who has spent his career working at the interface between technical innovation and successful business, working with organisations from multinational corporations to venture-funded start-ups. Prior to moving to build a portfolio career, […]
Professor Chris Molloy
Professor Chris Molloy has a 30-year international board and executive career across a unique range of life sciences R&D disciplines. His career began in preclinical research at Glaxo, where he was closely involved with the industrialisation of high throughput discovery. In 2004 he moved to Asia as COO of MerLion Pharmaceuticals, a Singaporean biotech that […]
Robert Sherville-Payne
With a professional legal and compliance background and over 25 years of commercial experience, Robert brings significant expertise as a solicitor to his role as General Counsel and Company Secretary at Medicines Discovery Catapult. Having trained and worked at law firm Hogan Lovells in London, Robert spent 14 years at AstraZeneca in a range of […]
Dr Emily Offer
Emily has 20 years’ experience in cell and molecular biology applied to drug discovery. Emily’s academic research involved the development and validation of stem cell derived models of disease and has subsequently led teams in large global pharma and biotech companies, developing cellular assays for both screening and phenotypic analysis of large and small molecule […]